Bill tracker, H.R. 1082, Health

Shandra Eisenga Human Cell and Tissue Product Safety Act

  1. Introduced
  2. In committee
  3. Reported
  4. Passed the House
  5. Passed the Senate
  6. To the President
  7. Became law

Introduced Feb 6, 2025 with 1 cosponsors. Latest action Jun 24, 2025: Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Sponsor

Committees

Timeline

CommitteeHouseSenatePresidentMarAprMayJunFeb 6, 2025: Introduced in HouseFeb 6, 2025: Referred to the House Committee on Energy and Commerce.Apr 29, 2025: Committee Consideration and Mark-up Session HeldApr 29, 2025: Ordered to be Reported by Voice Vote.Jun 12, 2025: Reported by the Committee on Energy and Commerce. H. Rept. 119-160.Jun 12, 2025: Placed on the Union Calendar, Calendar No. 127.Jun 23, 2025: Mr. Bilirakis moved to suspend the rules and pass the bill.Jun 23, 2025: Considered under suspension of the rules. (consideration: CR H2860-2862)Jun 23, 2025: DEBATE - The House proceeded with forty minutes of debate on H.R. 1082.Jun 23, 2025: Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H2860-2861)Jun 23, 2025: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H2860-2861)Jun 23, 2025: Motion to reconsider laid on the table Agreed to without objection.Jun 24, 2025: Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
PassedFailed, tabled or vetoedBecame lawOther steps

What happened to it

Related bills

Full history

    • ReferredSenate. Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
    • House. Motion to reconsider laid on the table Agreed to without objection.
    • House. On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H2860-2861)
    • Passed the HousePassed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H2860-2861)
    • House. DEBATE - The House proceeded with forty minutes of debate on H.R. 1082.
    • House. Considered under suspension of the rules. (consideration: CR H2860-2862)
    • House. Mr. Bilirakis moved to suspend the rules and pass the bill.
    • On the calendarHouse. Placed on the Union Calendar, Calendar No. 127.
    • ReportedReported by the Committee on Energy and Commerce. H. Rept. 119-160.
    • Committee approvedHouse. Ordered to be Reported by Voice Vote.
    • House. Committee Consideration and Mark-up Session Held
    • ReferredHouse. Referred to the House Committee on Energy and Commerce.
    • IntroducedIntroduced in House

Subjects

Administrative law and regulatory proceduresCivil actions and liabilityCongressional oversightDepartment of Health and Human ServicesHealth programs administration and fundingHealth promotion and preventive careOrgan and tissue donation and transplantation

Read the bill on Congress.gov